SCHEMBL4921370

SCHEMBL4921370

CCN1Cc2nc3c(-c4cc(F)cc(OC)c4)cccc3c(N)c2C1=O

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 5/20 0.37
▸ ENPP1 P22413 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.34
▸ SSTR2 P30874 3/20 0.33
▸ SCN9A Q15858 2/20 0.33
▸ CRHR1 P34998 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ LRRK2 Q5S007 2/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ GABRA2 P47869 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ SIK2 Q9H0K1 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ PDE6C P51160 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2661141 0.93 PDE5A (0.40) PDE5AENPP1HRH4CRHR1ADORA2A
SCHEMBL4921019 0.88 HRH4 (0.37) ENPP1HRH4SSTR2SCN9AADORA2A
SCHEMBL4920722 0.86 KDM4E (0.43) PDE5AENPP1HRH4CRHR1ADORA2A
SCHEMBL4924490 0.84 PDE5A (0.40) PDE5ACRHR1GABRA1GABRG2GABRB3
SCHEMBL2661952 0.84 PDE5A (0.40) PDE5AGABRA1GABRG2GABRB3GABRA5
SCHEMBL4915495 0.84 PDE5A (0.41) PDE5ASCN9AGABRA1GABRG2GABRB3
SCHEMBL4917169 0.84 PDE5A (0.42) PDE5AGABRA1GABRG2GABRB3GABRA5
SCHEMBL2661396 0.83 PDE5A (0.43) PDE5ACRHR1ADORA2AADORA1GABRA1
SCHEMBL2659840 0.83 GABRG2 (0.43) PDE5AENPP1CRHR1GABRG2GABRB3
SCHEMBL2657124 0.83 PDE5A (0.41) PDE5ASCN9ACRHR1ADORA2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF PDE5A 742/4885ENPP1 3350/4885HRH4 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback